Potential of osteopontin in the management of epithelial ovarian cancer

Osteopontin (sOPN) is a promising blood tumour marker for detecting epithelial ovarian cancer (EOC). However, other clinical uses of sOPN as a tumour marker in EOC are still lacking. Since sOPN concentrations in serum are not associated with those in ascites, we compared clinical value of sOPN conce...

Full description

Bibliographic Details
Main Authors: Cerne Katarina, Hadzialjevic Benjamin, Skof Erik, Verdenik Ivan, Kobal Borut
Format: Article
Language:English
Published: Sciendo 2019-01-01
Series:Radiology and Oncology
Subjects:
Online Access:https://doi.org/10.2478/raon-2019-0003
_version_ 1797848546963095552
author Cerne Katarina
Hadzialjevic Benjamin
Skof Erik
Verdenik Ivan
Kobal Borut
author_facet Cerne Katarina
Hadzialjevic Benjamin
Skof Erik
Verdenik Ivan
Kobal Borut
author_sort Cerne Katarina
collection DOAJ
description Osteopontin (sOPN) is a promising blood tumour marker for detecting epithelial ovarian cancer (EOC). However, other clinical uses of sOPN as a tumour marker in EOC are still lacking. Since sOPN concentrations in serum are not associated with those in ascites, we compared clinical value of sOPN concentrations in the two body fluids.
first_indexed 2024-04-09T18:30:24Z
format Article
id doaj.art-f947a85790224329af937ef4e327882f
institution Directory Open Access Journal
issn 1581-3207
language English
last_indexed 2024-04-09T18:30:24Z
publishDate 2019-01-01
publisher Sciendo
record_format Article
series Radiology and Oncology
spelling doaj.art-f947a85790224329af937ef4e327882f2023-04-11T17:19:27ZengSciendoRadiology and Oncology1581-32072019-01-0153110511510.2478/raon-2019-0003raon-2019-0003Potential of osteopontin in the management of epithelial ovarian cancerCerne Katarina0Hadzialjevic Benjamin1Skof Erik2Verdenik Ivan3Kobal Borut4Institute of Pharmacology and Experimental Toxicology, Faculty of Medicine, University Ljubljana, Ljubljana, SloveniaInstitute of Pharmacology and Experimental Toxicology, Faculty of Medicine, University Ljubljana, Ljubljana, SloveniaDepartment of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, SloveniaDepartment of Gynaecology, Division of Gynaecology and Obstetrics, University Medical Centre Ljubljana, Ljubljana, SloveniaDepartment of Gynaecology, Division of Gynaecology and Obstetrics, University Medical Centre Ljubljana, Ljubljana, SloveniaOsteopontin (sOPN) is a promising blood tumour marker for detecting epithelial ovarian cancer (EOC). However, other clinical uses of sOPN as a tumour marker in EOC are still lacking. Since sOPN concentrations in serum are not associated with those in ascites, we compared clinical value of sOPN concentrations in the two body fluids.https://doi.org/10.2478/raon-2019-0003advanced ovarian cancerosteopontinserumascites
spellingShingle Cerne Katarina
Hadzialjevic Benjamin
Skof Erik
Verdenik Ivan
Kobal Borut
Potential of osteopontin in the management of epithelial ovarian cancer
Radiology and Oncology
advanced ovarian cancer
osteopontin
serum
ascites
title Potential of osteopontin in the management of epithelial ovarian cancer
title_full Potential of osteopontin in the management of epithelial ovarian cancer
title_fullStr Potential of osteopontin in the management of epithelial ovarian cancer
title_full_unstemmed Potential of osteopontin in the management of epithelial ovarian cancer
title_short Potential of osteopontin in the management of epithelial ovarian cancer
title_sort potential of osteopontin in the management of epithelial ovarian cancer
topic advanced ovarian cancer
osteopontin
serum
ascites
url https://doi.org/10.2478/raon-2019-0003
work_keys_str_mv AT cernekatarina potentialofosteopontininthemanagementofepithelialovariancancer
AT hadzialjevicbenjamin potentialofosteopontininthemanagementofepithelialovariancancer
AT skoferik potentialofosteopontininthemanagementofepithelialovariancancer
AT verdenikivan potentialofosteopontininthemanagementofepithelialovariancancer
AT kobalborut potentialofosteopontininthemanagementofepithelialovariancancer